U.S. Steel shares jumped Monday on a report that Cleveland-Cliffs is teaming up with rival Nucor for a potential bid for the ...

U.S. equities were mixed at midday, with the Nasdaq losing more than 1% on worries about future Federal Reserve interest-rate cuts.

Mortgage rates continue to climb, jumping Friday to end the week at a new 7-month high. Rates rose for almost every other new purchase loan type as well.

JPMorgan Chase is scheduled to report earnings before the opening bell Wednesday, kicking off a stretch of earnings reports as America's largest financial institutions wrap up their 2024s.

Private student loans could become more prominent without the Education Department, depending on how the Trump Administration ...

JPMorgan raised its price target on Boot Barn Holdings after meeting with executives of the Western footwear and clothing retailer.

Retiring to Texas can save you money on income tax, housing prices, and other expenses. But there are a few catches to watch out for. Here's what you need to know.

Lululemon Athletica raised its fourth-quarter sales and profit projections after its finance chief said "guests responded well" to its product offering during the holiday season.

Billionaire Bill Ackman’s investment vehicle Pershing Square has offered to buy the remainder of real estate developer Howard ...

Sage Therapeutics reported that Biogen made an unsolicited offer to purchase all of the shares of the biopharmaceutical firm it doesn't already own.

U.S. stocks fell on Monday as Treasury yields continued to move higher amid doubts about the Fed's next move on interest rates.

Shares of Intra-Cellular Therapies are surging 35% in premarket trading Monday after Johnson & Johnson said it will acquire the biopharmaceutical company for roughly $14.6 billion.